Non-COX Arachidonic Acid Metabolites and Angiogenesis

非 COX 花生四烯酸代谢物和血管生成

• 批准号: 6868102
• 负责人: GADIPARTHI N RAO
• 金额: $ 36.5万
• 依托单位: UNIVERSITY OF TENNESSEE HEALTH SCI CTR
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-04-01 至 2008-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6868102
• 关键词: angiogenesis; apoptosis; arachidonate; atherosclerosis; cell migration; cell proliferation; diabetic retinopathy; eicosanoids; fibroblast growth factor; interleukin 8; laboratory mouse; lipoxygenase; neoplasm /cancer; oxidative stress; pathologic process; platelet activating factor; vascular endothelial growth factors; vascular smooth muscle

Inflammation that follows tissue injury is believed to be important in the initiation and progression of various diseases including, atherosclerosis, cancer, and retinopathy. Phospholipase A2s (PLA2s), a group of enzymes that breakdown phospholipids generating arachidonic acid and lysophospholipids have been implicated in inflammation. One of the major events underlying the progression of atherosclerosis is angiogenesis. Endothelial cell (EC) migration and proliferation are critical events in angiogenesis. Emerging evidence suggests that PLA2, arachidonic acid and its eicosanoid metabolites play a role in the regulation of cell migration, proliferation, and apoptosis. In addition, recent investigations using nonsteroidal anti-inflammatory drugs reveal a potential role for eicosanoids in angiogenesis. Based on this knowledge, we hypothesize that eicosanoids, particularly the lipoxygenase-monooxygenase metabolites of arachidonic acid, play an important role in angiogenesis and thereby influence the pathogenesis of atherosclerosis. To test the role of eicosanoids in angiogenesis we will address the following four specific aims: 1. To identify eicosanoids produced in human microvascular endothelial cells (HMVEC) and determine their effects on angiogenesis using in vitro and in vivo models. 2. To determine the effects of angiogenic eicosanoids on HMVEC migration and proliferation. 3. To test the role of the Jak/STAT and PI3K/Akt pathways in angiogenic eicosanoid-induced HMVEC migration and proliferation. 4. To identify the effector molecules of eicosanoid-induced angiogenesis and study the mechanisms underlying their regulation of expression in HMVEC and vascular smooth muscle cells. The results of this proposal will provide novel information on the identification of specific angiogenic eicosanoids and on elucidation of the underlying mechanisms by which these lipid molecules stimulate angiogenesis. Such knowledge, in turn, could be useful in developing therapeutics in the prevention of progression of diseases such as atherosclerosis.

据信，组织损伤后的炎症对于动脉粥样硬化、癌症和视网膜病等多种疾病的发生和进展很重要。磷脂酶 A2 (PLA2) 是一组分解磷脂产生花生四烯酸和溶血磷脂的酶，与炎症有关。动脉粥样硬化进展的主要事件之一是血管生成。内皮细胞（EC）迁移和增殖是血管生成的关键事件。新的证据表明 PLA2、花生四烯酸及其类二十烷酸代谢物在细胞迁移、增殖和凋亡的调节中发挥作用。此外，最近使用非甾体抗炎药的研究揭示了类二十烷酸在血管生成中的潜在作用。基于这些知识，我们假设类二十烷酸，特别是花生四烯酸的脂加氧酶-单加氧酶代谢物，在血管生成中发挥重要作用，从而影响动脉粥样硬化的发病机制。为了测试类二十烷酸在血管生成中的作用，我们将实现以下四个具体目标： 1. 鉴定人微血管内皮细胞 (HMVEC) 中产生的类二十烷酸，并使用体外和体内模型确定它们对血管生成的影响。 2.确定血管生成类二十烷酸对HMVEC迁移和增殖的影响。 3. 测试Jak/STAT和PI3K/Akt通路在血管生成类二十烷酸诱导的HMVEC迁移和增殖中的作用。 4. 鉴定类二十烷酸诱导血管生成的效应分子，并研究其在HMVEC和血管平滑肌细胞中表达的调节机制。该提案的结果将为鉴定特定的血管生成类二十烷酸和阐明这些脂质分子刺激血管生成的潜在机制提供新的信息。这些知识反过来可能有助于开发预防动脉粥样硬化等疾病进展的疗法。